These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16556692)

  • 21. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease.
    Gessner C; Scheibe R; Wötzel M; Hammerschmidt S; Kuhn H; Engelmann L; Hoheisel G; Gillissen A; Sack U; Wirtz H
    Respir Med; 2005 Oct; 99(10):1229-40. PubMed ID: 16140223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers in obstructive respiratory diseases: an update.
    Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
    Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
    Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
    Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exhaled breath condensate and airway inflammation.
    Hoffmeyer F; Raulf-Heimsoth M; Brüning T
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):16-22. PubMed ID: 19532089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeatability of inflammatory parameters in induced sputum of COPD patients.
    Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
    COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOPE-preservation of paraffin-embedded sputum samples--a new way of bioprofiling in COPD.
    Pedersen F; Marwitz S; Seehase S; Kirsten AM; Zabel P; Vollmer E; Rabe KF; Magnussen H; Watz H; Goldmann T
    Respir Med; 2013 Apr; 107(4):587-95. PubMed ID: 23312618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients.
    Tateosian NL; Costa MJ; Guerrieri D; Barro A; Mazzei JA; Eduardo Chuluyan H
    Cytokine; 2012 Jun; 58(3):361-7. PubMed ID: 22469918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
    Casado B; Iadarola P; Luisetti M; Kussmann M
    Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease.
    Yoshikawa T; Dent G; Ward J; Angco G; Nong G; Nomura N; Hirata K; Djukanovic R
    Am J Respir Crit Care Med; 2007 Mar; 175(5):473-9. PubMed ID: 17110644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory markers in COPD.
    Larsson K
    Clin Respir J; 2008 Oct; 2 Suppl 1():84-7. PubMed ID: 20298355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The validity of induced sputum and bronchoalveolar lavage in childhood asthma.
    Kim CK; Koh YY; Callaway Z
    J Asthma; 2009 Mar; 46(2):105-12. PubMed ID: 19253112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exhaled breath condensate analysis in patients with COPD.
    Montuschi P
    Clin Chim Acta; 2005 Jun; 356(1-2):22-34. PubMed ID: 15936301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease.
    Kohler M; Sandberg A; Kjellqvist S; Thomas A; Karimi R; Nyrén S; Eklund A; Thevis M; Sköld CM; Wheelock ÅM
    J Allergy Clin Immunol; 2013 Mar; 131(3):743-51. PubMed ID: 23146379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease.
    Kersul AL; Iglesias A; Ríos Á; Noguera A; Forteza A; Serra E; Agustí A; Cosío BG
    Arch Bronconeumol; 2011 Apr; 47(4):176-83. PubMed ID: 21454005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of chronic obstructive pulmonary disease with inhaled pharmacotherapy: role of corticosteroids].
    Kardos Z
    Acta Pharm Hung; 2012; 82(1):33-41. PubMed ID: 22570985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Importance of the distal airway in COPD].
    Cosío BG; Rodríguez Rosado J
    Arch Bronconeumol; 2011 Apr; 47 Suppl 2():32-7. PubMed ID: 21640283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
    Malerba M; Ragnoli B; Corradi M
    Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease.
    Turino GM; Ma S; Lin YY; Cantor JO; Luisetti M
    Am J Respir Crit Care Med; 2011 Sep; 184(6):637-41. PubMed ID: 21757624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease models of chronic inflammatory airway disease: applications and requirements for clinical trials.
    Diamant Z; Clarke GW; Pieterse H; Gispert J
    Curr Opin Pulm Med; 2014 Jan; 20(1):37-45. PubMed ID: 24231465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.